
Ipamorelin
Selective Growth Hormone Secretagogue (GHRP)
Ipamorelin is a selective growth hormone releasing peptide (GHRP) that specifically stimulates the release of growth hormone without affecting other hormones. Unlike other GHRPs, Ipamorelin does not increase cortisol, acetylcholine, prolactin, or aldosterone levels, making it the most selective and well-tolerated growth hormone secretagogue available for research and therapeutic applications.
Complete Dosing Guide
Quick Reference
Administration Method
Subcutaneous injection 1-3 times daily
Step-by-Step Dosing Protocol
Dosing Guidelines
Initial dosing begins at 100 mcg once daily, typically administered in the evening to complement natural growth hormone pulsatile release. After 1-2 weeks of tolerance assessment, dosing can be increased to 100 mcg twice daily (morning and evening), and subsequently to 100 mcg three times daily (morning, post-workout, and bedtime) for a total daily dose of 300 mcg. Doses are administered via subcutaneous injection on an empty stomach for optimal absorption and GH release.
Most people start with a small dose (100 mcg) once a day in the evening to test how their body responds. After a week or two, you can increase to twice a day (morning and evening). Eventually, some people take it three times a day - when they wake up, after workouts, and before bed. The key is to take it on an empty stomach (at least 1 hour before or 2 hours after eating) for the best results.
Mixing & Injection
Subcutaneous injection using insulin syringes (typically 0.5mL/1mL capacity with 29-31 gauge needles). Common injection sites include the abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water (typical ratio: 2mL bacteriostatic water per 5mg vial). Store reconstituted solution refrigerated and use within 28 days.
Subcutaneous injection using insulin syringes (typically 0.5mL/1mL capacity with 29-31 gauge needles). Common injection sites include the abdominal area (2 inches from navel), anterior thigh, or deltoid region. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water (typical ratio: 2mL bacteriostatic water per 5mg vial). Store reconstituted solution refrigerated and use within 28 days.
Clinical Administration Guidelines
Injection Protocol
- •Subcutaneous injection per protocol
- •Rotate injection sites
- •Consistent daily timing
- •Follow protocol guidelines
Monitoring Schedule
- •Regular progress monitoring
- •Health parameter monitoring
- •Laboratory monitoring
- •Safety monitoring
Dosage Calculator
Medical Disclaimer
Ipamorelin is currently in research phase and is not FDA-approved for human therapeutic use. This information is for educational purposes only and should not replace consultation with healthcare providers. Individual results may vary. Medical supervision is recommended for all research applications.